Tissue factor pathway of coagulation in sepsis

Critical Care Medicine

Volumn 28, Issue 9 SUPPL., 2000, Pages

  Hack, C E ^a  

^a CENTRAL LABORATORY   (Netherlands)

Author keywords

Animals; Coagulation; Humans; Inflammation; Sepsis; Tissue factor pathway

Indexed keywords

BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; INTERLEUKIN 1; KININOGEN; PREKALLIKREIN; PROTEIN C; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR; TUMOR NECROSIS FACTOR;

BLOOD CLOTTING; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISEASE COURSE; DISSEMINATED INTRAVASCULAR CLOTTING; ENZYME ACTIVITY; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVIEW; SEPSIS;

EID: 0033810385     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200009001-00006     Document Type: Review

References (65)

1. Role of cytokines in sepsis
2. Blood coagulation. The thrombin paradox
3. Tissue factor in health and disease
4. Blood-borne tissue factor: Another view of thrombosis
5. Tissue factor expression by monocytes: Regulation and pathophysiological roles
6. Complement-mediated regulation of tissue factor activity in endothelium
7. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: Characterization and comparison with the actions of interleukin 1
8. Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anti-coagulant activity
9. Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells
10. Cultured human endothelial cells generate tissue factor in response to endotoxin
11. Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro
12. Tissue factor pathway inhibitor (TFPI)-an update
13. Regulation of tissue factor initiated thrombin generation by the stoichiometric inhibitors tissue factor pathway inhibitor, antithrombin-III, and heparin cofactor-II
14. Factor XI activation in a revised model of blood coagulation
15. Activation of human blood coagulation factor XI independent of factor XII: Factor XI is activated by thrombin and factor XIa in the presence of negatively charged surfaces
16. Activation of clotting factor XI without detectable contact activation in experimental human endotoxemia
17. The role of factor XI in coagulation: A matter of revision
18. Thrombin-mediated activation of factor XI results in a thrombin-activatable fibrinolysis inhibitor-dependent inhibition of fibrinolysis
19. Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis
20. Enhancement of rabbit jugular vein thrombolysis by neutralization of factor XI: In vivo evidence for a role of factor XI as an anti-fibrinolytic factor
21. Divergent efficacy of antibody to tumor necrosis factor-alpha in intravascular and peritonitis models of sepsis
22. Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees
23. Effects of plasma kallikrein specific inhibitor and active-site blocked factor VIIa on the pulmonary vascular injury induced by endotoxin in rats
24. Effect of nafamostat mesilate on pulmonary vascular injury induced by lipopolysaccharide in rats
25. Interleukin 1-induced pathophysiology: Induction of cytokines, development of histopathologic changes, and immunopharmacologic intervention
26. Role of tumor necrosis factor-alpha in lipopolysaccharide-induced pathologic alterations
27. Acute inflammation and a Shwartzman-like reaction induced by interleukin-1 and tumor necrosis factor: Synergistic action of the cytokines in the induction of inflammation and microvascular injury
28. Activation of coagulation after administration of tumor necrosis factor to normal subjects
29. Fibrinolytic response to tumor necrosis factor in healthy subjects
30. Infusion of phospholipid vesicles amplifies the local thrombotic response to TNF and anti-protein C into a consumptive response
31. Contribution of interleukin-1 to activation of coagulation and fibrinolysis, neutrophil degranulation, and the release of secretory-type phospholipase A2 in sepsis: Studies in nonhuman primates after interleukin-1 alpha administration and during lethal bacteremia
32. Interleukin-6 stimulates coagulation, not fibrinolysis, in humans
33. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor
34. Interleukin-2 induces activation of coagulation and fibrinolysis: Resemblance to the changes seen during experimental endotoxaemia
35. Interleukin-12 induces sustained activation of multiple host inflammatory mediator systems in chimpanzees
36. Complete inhibition of endotoxin-induced coagulation activation in chimpanzees with a monoclonal Fab fragment against factor VII/VIIa
37. Differential effects of anti-tumor necrosis factor monoclonal antibodies on systemic inflammatory responses in experimental endotoxemia in chimpanzees
38. Experimental endotoxemia in humans: Analysis of cytokine release and coagulation, fibrinolytic, and complement pathways
39. Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects
40. Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees
41. Activation patterns of coagulation and fibrinolysis in baboons following infusion with lethal or sublethal dose of Escherichia coli
42. Pretreatment with a 55-kDa tumor necrosis factor receptor-immunoglobulin fusion protein attenuates activation of coagulation, but not of fibrinolysis, during lethal bacteremia in baboons
43. Recombinant human antithrombin III improves survival and attenuates inflammatory responses in baboons lethally challenged with Escherichia coli
44. Macrophages and neutrophils infiltrating into the liver are responsible for tissue factor expression in a rabbit model of acute obstructive cholangitis
45. Possible role of platelet-activating factor in the in vivo expression of tissue factor in neutrophils
46. Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal Escherichia coli sepsis
47. Enhanced endothelial tissue factor but normal thrombomodulin in endotoxin-treated rabbits
48. Enhanced endothelial tissue factor but normal thrombomodulin in endotoxin-treated rabbits
49. Murine tissue factor gene expression in vivo: Tissue and cell specificity and regulation by lipopolysaccharide
50. Lipopolysaccharide induction of tissue factor expression in rabbits
51. Expression of tissue factor and tissue factor pathway inhibitor in rat lungs with lipopolysaccharide-induced disseminated intravascular coagulation
52. Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccharide
53. Cellular origin and procoagulant properties of microparticles in meningococcal sepsis
54. Prevention of endotoxin-induced mortality by antitissue factor immunization
55. Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody
56. Active site inhibited factor VIIa (DEGR VIIa) attenuates the coagulant and interleukin-6 and -8, but not tumor necrosis factor, responses of the baboon to LD100 Escherichia coli
57. Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock
58. Recombinant E. coli-derived tissue factor pathway inhibitor reduces coagulopathic and lethal effects in the baboon gram-negative model of septic shock
59. Attenuation of tissue thrombosis and hemorrhage by ala-TFPI does not account for its protection against E. coli: A comparative study of treated and untreated non-surviving baboons challenged with LD100 E. coli
60. The effect of two-domain tissue factor pathway inhibitor on endotoxin-induced disseminated intravascular coagulation in rabbits
61. Effects of recombinant human tissue factor pathway inhibitor on thrombus formation and its in vivo distribution in a rat DIC model
62. Disseminated intravascular coagulation in rabbits induced by administration of endotoxin or tissue factor: Effect of anti-tissue factor antibodies and measurement of plasma extrinsic pathway inhibitor activity
63. Randomized, blinded, placebo-controlled trial of tissue factor pathway inhibitor in porcine septic shock
64. Delayed treatment with recombinant human tissue factor pathway inhibitor improves survival in rabbits with gram-negative peritonitis
65. DEGR-factor Xa blocks disseminated intravascular coagulation initiated by Escherichia coli without preventing shock or organ damage